Vicapsys Life Sciences, Inc. VICP
Set alert
0.45 USD +0.05 +12.50%
At close · Oct 29
0.45 Day range 0.45
0.15 52-week range 1.50
- YTD
- -70.00%
- 1 year
- -70.00%
- Open
- 0.45
- Prev close
- 0.40
- Mkt cap
- 14.57M
- Vol
- 110
- Avg vol
- 1.28K
- EPS
- -0.01
- P/E
- 0.00
More statistics
- Low
- 0.45
- High
- 0.45
- Earnings
- Oct 21, 2024
2Y chart
Signals (20)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| RSI: Oversold | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | May 1, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 25, 2026 | 7 months ago |
| MACD: Buy Signal | Nov 12, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 23, 2025 | 1 year ago |
| RSI: Oversold | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | May 29, 2025 | 1 year ago |
| SMA: Bullish | Apr 10, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 1, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 21, 2025 | 1 year ago |
| RSI: Oversold | Mar 20, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 13, 2025 | 1 year ago |
Next earnings
Oct 21, 2024
Expected Oct 21, 2024. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 21, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | — | — | — |
| Aug 16, 2022 | Jun 1, 2022 | 0.00 | -0.01 | — | — |
| Sep 20, 2021 | Mar 1, 2021 | 0.00 | 0.00 | — | — |
| Sep 9, 2021 | Jun 1, 2020 | 0.00 | — | — | — |
News
- Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary
- Vicapsys Life Sciences Announces Advisory Board Following Completion of Stateline Merger
- RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets
- Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets
Your note
Sign in to keep a note on VICP — it syncs with the Stock Master app.